TP53 and glioblastoma: More preclinical studies reported that JNJ-26854165 increased p53 levels in U87 glioblastoma grafts, accompanied by apoptotic stimulation.373–376 In addition, JNJ-26854165 induces antitumor effects in breast, lung, colon, and prostate tumor models with mutant p53.